Picture of Biomed Lublin Wytwornia Surowic i Szczepionek SA logo

BML Biomed Lublin Wytwornia Surowic i Szczepionek SA Cashflow Statement

0.000.00%
pl flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Annual cashflow statement for Biomed Lublin Wytwornia Surowic i Szczepionek SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

C2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
PAS
PAS
PAS
PAS
PAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1.68-38.23.724.315.89
Depreciation
Amortisation
Non-Cash Items-16.8-1.33-0.79-0.614-2.79
Unusual Items
Other Non-Cash Items
Changes in Working Capital2.254.77-0.604-9.18-12.9
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities4.36-0.6198.160.343-3.28
Capital Expenditures-0.484-2.64-0.806-2.02-18.4
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items5.820.11613.9
Sale of Fixed Assets
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities5.34-2.64-0.69-2.02-4.49
Financing Cash Flow Items-3.31-2.44-1.15-1.05-0.892
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-8.051-6.872.8620.2
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1.65-2.260.6021.1812.5

Or unlock with your email

Or unlock with your email